(IN BRIEF) Merck, a prominent science and technology company, has entered into a strategic partnership with Jiangsu Hengrui Pharmaceuticals. This collaboration includes an exclusive global license (excluding China) to develop and commercialize Hengrui’s advanced PARP1 inhibitor, HRS-1167. Additionally, there is … Read the full press release
Posted in Germany, Healthcare, Pharma & Biotech
Tagged ADC, antibody-drug conjugate, ATM, ATR, Cancer, CEACAM5-targeting ADC, Claudin-18.2, Danny Bar-Zohar, DDR cascade, DNA-PK, Frank Jiang, Hengrui, HRS-1167, inhibitor, Jiangsu Hengrui Pharmaceuticals Co. Ltd., M9140, Merck, metastatic colorectal cancer, oncology, PARP, PARP1, poly (ADP-ribose) polymerase 1, SHR-A1904
(IN BRIEF) Merck, a leading science and technology company, has announced its expectation to return to organic sales growth in fiscal 2024. This was revealed during the company’s Capital Markets Day. Despite challenging market conditions in its Life Science and … Read the full press release
Posted in Artificial Intelligence (AI), Business, Electronics & Machinery, Financial, Germany, Healthcare, Management, Pharma & Biotech, Technology
Tagged artificial-intelligence, BAVENCIO™, Belén Garijo, Capital Markets Day, electronics, evobrutini, Healthcare, Internet of Things, IoT, Life Science, MAVENCLAD, Merck, semiconductor materials, Xevinapant
(IN BRIEF) Merck, a leading science and technology company, is set to present 28 abstracts at the 2023 European Society of Medical Oncology (ESMO) Annual Meeting in Madrid. These abstracts will showcase the latest research on Merck’s oncology portfolio, addressing … Read the full press release
Posted in Business, Germany, Healthcare, Management, Media, News, Pharma & Biotech, Science, Spain, Technology
Tagged BAVENCIO™, bladder, cancer treatment, colorectal, ERBITUX, ESMO 2023, head and neck, lung, Madrid, Merck, oncology, TEPMETKO, Xevinapant
(IN BRIEF) Merck has presented new data on evobrutinib, an investigational BTK inhibitor, at the 9th Joint ECTRIMS-ACTRIMS congress. The data from an ongoing Phase II open-label extension study of evobrutinib in patients with relapsing multiple sclerosis (RMS) show sustained … Read the full press release
Posted in Business, Education, Germany, Healthcare, Industrial, Management, News, Pharma & Biotech, Science
Tagged BTKi, Evobrutinib, Jan Klatt, Merck, multiple sclerosis, relapsing multiple sclerosis (RMS), treatment
(IN BRIEF) Merck, a prominent science and technology company, has revealed new findings from the MAVENCLAD® (cladribine tablets) MAGNIFY-MS study at the 9th Joint ECTRIMS-ACTRIMS meeting in Milan. The study demonstrated that patients with relapsing multiple sclerosis (RMS) experienced a … Read the full press release
Posted in Business, Germany, Healthcare, Industrial, Management, News, Pharma & Biotech, Science
Tagged Alexander Kulla, MAVENCLAD, Merck, multiple sclerosis, Neuronal Injury, reduction
(IN BRIEF) Merck, a prominent science and technology company, has entered into a collaboration with the United Nations’ Global Initiative on Ageing (GIA) to offer a training course aimed at equipping family carers with essential skills. The course comprises five … Read the full press release
Posted in Business, Education, Germany, Healthcare, Industrial, Management, Media, News, Pharma & Biotech, Science
Tagged caregivers, Embracing Carers®, European Carers Day, Family Carers, Global Initiative on Ageing (GIA), Luis Gallegos, Merck, partnership, Peter Guenter, training course, United Nations
(IN BRIEF) Merck, a prominent science and technology company, has announced strategic drug discovery collaborations with AI technology firms BenevolentAI and Exscientia. These partnerships aim to leverage AI-driven design and discovery capabilities to advance research efforts in key therapeutic areas, … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged AI, AI-Driven Drug, BenevolentAI, Danny Bar-Zohar, data, Exscientia, immunology, Merck, Neurology, oncology, partnership, science
(IN BRIEF) Merck will showcase innovative ideas and new products for the paint and coatings industry at the European Coatings Show 2023 in Germany. One of the highlights will be the latest pigment development from the company that enables Surface … Read the full press release
Posted in Automotive, Business, Chemicals, Germany, Management, Media, News, Science, Technology
Tagged automotive coatings, Colorstream®, European Coatings Show 2023, exhibit, F20-52 SW Mineral Red pigment, Germany, innovative, Merck, Nuremberg, pigment, silica pigment
(IN BRIEF) Merck and Intel have signed a memorandum of understanding to invest in a new academic research program aimed at driving innovation in semiconductor manufacturing processes and technologies using artificial intelligence (AI) and machine learning. The companies will jointly … Read the full press release
Posted in Artificial Intelligence (AI), Education, Environment, Germany, Healthcare, News, Pharma & Biotech, Science
Tagged artificial intelligence (AI), David Nessim, Dr. Beate Burkhart, Europe, Intel, Machine Learning, Manufacturing, Merck, partnership, RESEARCH, semiconductor, sustainable, technology
(PRESS RELEASE) DARMSTADT, 24-Jan-2022 — /EuropaWire/ — Merck (ETR: MRK), a German multinational leading science and technology company in healthcare, life science, electronics, has announced the company hit a milestone mark in its donation of praziquantel for the treatment of … Read the full press release
Posted in Germany, Healthcare, News, Non Profit, Pharma & Biotech, Society
Tagged central Africa, donation, DRC, medication, Merck, NTDs, parasitic diseases, Peter Guenter, praziquantel, public health, Rwanda, schistosomiasis, Schistosomiasis Elimination Program, schoolchildren, tropical countries, WHO, World Health Organization
New product specifically for the needs of aging skin Essential calcium improves overall skin integrity Halal-certified blend of 100% of plant and mineral origin serves sustainable market trends (PRESS RELEASE) DARMSTADT, 11-Oct-2021 — /EuropaWire/ — Merck (ETR: MRK), a German … Read the full press release
Posted in Germany, News, Pharma & Biotech, Science, Technology
Tagged cosmetic ingredient, dermocosmetics, epidermis, hydrophilic, mature skin, Merck, natural amino acids, Natural Moisturizing Factor, natural skin aging, RonaCare® Epintegrity, skin, skin care, Skin cells, skin hydration, Wiebke Dondras
(PRESS RELEASE) DARMSTADT, 6-Aug-2021 — /EuropaWire/ — The Merck Group (ETR: MRK), a German multinational science and technology company, has announced some leadership changes within its business sector Electronics. Effective September 1, 2021, Jeff White, currently Head of Delivery Systems … Read the full press release
Innovation Center project of Merck aims to develop smart neurostimulators for targeted treatment of chronic diseases Second collaboration within the Bioelectronics innovation field of Merck focuses on increasing the selectivity and power efficiency of the device to enable energy intensive … Read the full press release
Posted in Germany, Healthcare, News, Pharma & Biotech, Science, Spain, Technology
Tagged bioelectronic, bioelectronic therapies, bioelectronics, Bioelectronics innovation, Carolina Aguilar, chronic diseases, electronic therapies, endocrine disorders, graphene, graphene electrodes, graphene interfaces, Inbrain Neuroelectronics, inflammatory disorders, Innervia Bioelectronics, Jurriaan Baker, Laura Matz, Merck, metabolic disorders, neuroloop GmbH, neurostimulators, physiological datasets, precise signal coding, Reduced Graphene Oxide, rGO, Robert Spoelgen, selective neurostimulation, start-up, vagus nerve
Closing of sale to Procter & Gamble at a cash purchase price of € 3.4 billion completed Successful completion allows Merck to further focus on innovation driven businesses in Healthcare, Life Science and Performance Materials Transaction successfully closed within an ambitious timeframe … Read the full press release
Posted in Business, Germany, Healthcare, Pharma & Biotech
Tagged acquisition, Belén Garijo, divestment, health, Marcus Kuhnert, Merck, P&G, Procter & Gamble, science
Merck today (12 NOV 2018) signed an agreement with the Guangzhou Development District on innovation development in Southern China. DARMSTADT, Germany / GUANGZHOU, China, 14-Nov-2018 — /EuropaWire/ — Merck, the vibrant science and technology company, today signed an agreement with the … Read the full press release
Posted in Germany, Healthcare, Pharma & Biotech, Technology
Tagged CHINA, Gangolf Schrimpf, Guangzhou, Huangpu, INNOVATION, Innovation Hub, Kai Beckmann, Merck, RESEARCH, science
Lynparza met primary endpoint of progression-free survival in women with BRCA-mutated advanced ovarian cancer and showed a safety profile consistent with previous trials AstraZeneca and MSD’s Lynparza is the only PARP inhibitor to demonstrate significant activity in the 1st-line maintenance … Read the full press release
Posted in Healthcare, Pharma & Biotech, United Kingdom
Tagged AstraZeneca, Cancer, Lynparza, Merck, Olaparib, ovarian_cancer
Merck today (23 APR 2018) announced that the Chinese Patent Office has issued a notice granting Merck’s patent application for the company’s CRISPR technology used in a genomic-integration method for eukaryotic cells. Patent in China covers integration of an external … Read the full press release
Posted in Business, Germany, Healthcare, Law, Pharma & Biotech, Science, Technology
Tagged Chinese Patent Office, CRISPR technology, eukaryotic cells, eukaryotic_cells, genome, genomic-integration method, Merck, patent, science, Udit Batra
First Health Canada approved treatment for rare and aggressive type of skin cancer MISSISSAUGA, ON, 26-Feb-2018 — /EuropaWire/ — Merck, which operates as EMD Serono in the US and Canada, and Pfizer Canada Inc. announced that Health Canada has approved BAVENCIO™ … Read the full press release
Posted in Germany, Healthcare, Pharma & Biotech
Tagged BAVENCIO™, cancer #skin cancer, Dr. John Walker, EMD Serono, health, Health Canada, Kathy Barnard, Merck, Merkelcell carcinoma, Pfizer Canada, skin, tumour
Toepfer joins from Metro Group, where he served as Head of the IT service company Metro Systems DARMSTADT, 26-Jan-2018 — /EuropaWire/ — Merck, a leading science and technology company, today announced that Dirk Toepfer will join the Group as the new … Read the full press release
Posted in Business, Chemicals, Germany, Management, Pharma & Biotech, Technology
Tagged chemical, Dirk Toepfer, Merck, Pharmaceutical, Udit Batra
Not intended for US/Canada based media The presentation of the grants coincides with the 10th International Meeting of Pediatric Endocrinology The awards program supports advancements in the field of growth and growth disorders DARMSTADT, 19-Sep-2017 — /EuropaWire/ — Merck, a leading … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?